Harbourvest Partners’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-837
| Closed | -$13.8K | – | 29 |
|
2024
Q3 | $13.8K | Hold |
837
| – | – | 0.01% | 34 |
|
2024
Q2 | $16K | Hold |
837
| – | – | 0.01% | 38 |
|
2024
Q1 | $22.4K | Hold |
837
| – | – | 0.01% | 45 |
|
2023
Q4 | $11.5K | Hold |
837
| – | – | ﹤0.01% | 53 |
|
2023
Q3 | $13K | Hold |
837
| – | – | ﹤0.01% | 58 |
|
2023
Q2 | $18.1K | Hold |
837
| – | – | 0.01% | 58 |
|
2023
Q1 | $14.9K | Hold |
837
| – | – | 0.01% | 63 |
|
2022
Q4 | $14.2K | Hold |
837
| – | – | ﹤0.01% | 65 |
|
2022
Q3 | $28K | Hold |
837
| – | – | 0.01% | 66 |
|
2022
Q2 | $47K | Hold |
837
| – | – | 0.02% | 61 |
|
2022
Q1 | $49K | Hold |
837
| – | – | 0.01% | 65 |
|
2021
Q4 | $60K | Hold |
837
| – | – | 0.01% | 66 |
|
2021
Q3 | $68K | Hold |
837
| – | – | 0.01% | 56 |
|
2021
Q2 | $81K | Hold |
837
| – | – | 0.01% | 49 |
|
2021
Q1 | $101K | Hold |
837
| – | – | 0.01% | 41 |
|
2020
Q4 | $109K | Hold |
837
| – | – | 0.04% | 24 |
|
2020
Q3 | $88K | Hold |
837
| – | – | 0.03% | 33 |
|
2020
Q2 | $215K | Hold |
837
| – | – | 0.09% | 26 |
|
2020
Q1 | $372K | Buy |
+837
| New | +$372K | 0.18% | 29 |
|